190 related articles for article (PubMed ID: 25922070)
1. Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport.
Long W; Panwar P; Witkowska K; Wong K; O'Neill D; Chen XZ; Lemieux MJ; Cheeseman CI
J Biol Chem; 2015 Jun; 290(24):15292-303. PubMed ID: 25922070
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key Residues for Urate Specific Transport in Human Glucose Transporter 9 (hSLC2A9).
Long W; Panigrahi R; Panwar P; Wong K; O Neill D; Chen XZ; Lemieux MJ; Cheeseman CI
Sci Rep; 2017 Jan; 7():41167. PubMed ID: 28117388
[TBL] [Abstract][Full Text] [Related]
3. Identification of a hydrophobic residue as a key determinant of fructose transport by the facilitative hexose transporter SLC2A7 (GLUT7).
Manolescu A; Salas-Burgos AM; Fischbarg J; Cheeseman CI
J Biol Chem; 2005 Dec; 280(52):42978-83. PubMed ID: 16186102
[TBL] [Abstract][Full Text] [Related]
4. SLC2A9 is a high-capacity urate transporter in humans.
Caulfield MJ; Munroe PB; O'Neill D; Witkowska K; Charchar FJ; Doblado M; Evans S; Eyheramendy S; Onipinla A; Howard P; Shaw-Hawkins S; Dobson RJ; Wallace C; Newhouse SJ; Brown M; Connell JM; Dominiczak A; Farrall M; Lathrop GM; Samani NJ; Kumari M; Marmot M; Brunner E; Chambers J; Elliott P; Kooner J; Laan M; Org E; Veldre G; Viigimaa M; Cappuccio FP; Ji C; Iacone R; Strazzullo P; Moley KH; Cheeseman C
PLoS Med; 2008 Oct; 5(10):e197. PubMed ID: 18842065
[TBL] [Abstract][Full Text] [Related]
5. A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity.
Manolescu AR; Augustin R; Moley K; Cheeseman C
Mol Membr Biol; 2007; 24(5-6):455-63. PubMed ID: 17710649
[TBL] [Abstract][Full Text] [Related]
6. Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice.
Toyoda Y; Takada T; Miyata H; Matsuo H; Kassai H; Nakao K; Nakatochi M; Kawamura Y; Shimizu S; Shinomiya N; Ichida K; Hosoyamada M; Aiba A; Suzuki H
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18175-18177. PubMed ID: 32690690
[TBL] [Abstract][Full Text] [Related]
7. Uric acid transport and disease.
So A; Thorens B
J Clin Invest; 2010 Jun; 120(6):1791-9. PubMed ID: 20516647
[TBL] [Abstract][Full Text] [Related]
8. Mouse GLUT9: evidences for a urate uniporter.
Bibert S; Hess SK; Firsov D; Thorens B; Geering K; Horisberger JD; Bonny O
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F612-9. PubMed ID: 19587147
[TBL] [Abstract][Full Text] [Related]
9. Solute carrier family 2, member 9 and uric acid homeostasis.
Cheeseman C
Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):428-32. PubMed ID: 19593129
[TBL] [Abstract][Full Text] [Related]
10. Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
Witkowska K; Smith KM; Yao SY; Ng AM; O'Neill D; Karpinski E; Young JD; Cheeseman CI
Am J Physiol Renal Physiol; 2012 Aug; 303(4):F527-39. PubMed ID: 22647630
[TBL] [Abstract][Full Text] [Related]
11. Facilitative glucose transporter 9, a unique hexose and urate transporter.
Doblado M; Moley KH
Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E831-5. PubMed ID: 19797240
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters.
Ebert K; Ludwig M; Geillinger KE; Schoberth GC; Essenwanger J; Stolz J; Daniel H; Witt H
J Membr Biol; 2017 Apr; 250(2):171-182. PubMed ID: 28083649
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system.
Clémençon B; Lüscher BP; Fine M; Baumann MU; Surbek DV; Bonny O; Hediger MA
PLoS One; 2014; 9(10):e108852. PubMed ID: 25286413
[TBL] [Abstract][Full Text] [Related]
14. Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes.
Zhang B; Duan M; Long B; Zhang B; Wang D; Zhang Y; Chen J; Huang X; Jiao Y; Zhu L; Zeng X
Mol Med Rep; 2019 Aug; 20(2):1645-1654. PubMed ID: 31257523
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in urate metabolism].
Mori G; Percudani R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960017
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
[TBL] [Abstract][Full Text] [Related]
17. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice.
Wang CP; Wang X; Zhang X; Shi YW; Liu L; Kong LD
J Pharm Pharm Sci; 2010; 13(3):411-27. PubMed ID: 21092713
[TBL] [Abstract][Full Text] [Related]
18. SLC2A9--a fructose transporter identified as a novel uric acid transporter.
Le MT; Shafiu M; Mu W; Johnson RJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2746-9. PubMed ID: 18606621
[No Abstract] [Full Text] [Related]
19. Urate transporters: an evolving field.
Anzai N; Endou H
Semin Nephrol; 2011 Sep; 31(5):400-9. PubMed ID: 22000646
[TBL] [Abstract][Full Text] [Related]
20. Recent advances on uric acid transporters.
Xu L; Shi Y; Zhuang S; Liu N
Oncotarget; 2017 Nov; 8(59):100852-100862. PubMed ID: 29246027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
